Literature DB >> 35979067

Role of cats in human toxocarosis.

Pablo David Jimenez Castro1, Sarah Gh Sapp2.   

Abstract

Toxocara cati, the feline ascarid, is ubiquitous in domestic cats globally and is increasingly recognised as an important zoonotic species. In the definitive host, infections with the adult ascarid usually do not present any clinical signs; if clinical signs do appear, it is usually in kittens infected with T. cati, especially by the transmammary route. Diseases may include cachexia, a pot-bellied appearance, respiratory disorders, diarrhoea, vomiting, among other signs, and these may present as early as 3 weeks of age. However, infections with Toxocara spp. larvae in paratenic hosts (including humans and many other animals), can result in serious complications from the migration of larvae. Historically, there has been an assumption that Toxocara canis was the most likely cause of Toxocara spp.-related disease; while it is probably true that T. canis is responsible for the majority of infections, it is important that those caused by T. cati are accurately identified so that the contribution of this parasite to human disease can be established and then handled appropriately. Overall, the detection of infections in cats and the control of parasite stages in the environment are essential to minimise the infection risk to other animals or humans.

Entities:  

Keywords:  Toxocara cati; control; human toxocarosis; prevention; zoonosis

Year:  2020        PMID: 35979067      PMCID: PMC9380441          DOI: 10.12968/coan.2020.0104

Source DB:  PubMed          Journal:  Companion Anim        ISSN: 2053-0889


  56 in total

Review 1.  Global and regional seroprevalence estimates for human toxocariasis: A call for action.

Authors:  Guangxu Ma; Ali Rostami; Tao Wang; Andreas Hofmann; Peter J Hotez; Robin B Gasser
Journal:  Adv Parasitol       Date:  2020-04-25       Impact factor: 3.870

Review 2.  Human toxocariasis: diagnosis, worldwide seroprevalences and clinical expression of the systemic and ocular forms.

Authors:  G Rubinsky-Elefant; C E Hirata; J H Yamamoto; M U Ferreira
Journal:  Ann Trop Med Parasitol       Date:  2010-01

3.  Toxocara cati larvae in the eye of a child: a case report.

Authors:  Mohammad Zibaei; Seyed Mahmoud Sadjjadi; Seyed Hamidreza Jahadi-Hosseini
Journal:  Asian Pac J Trop Biomed       Date:  2014-05

4.  Differential serodiagnostics of Toxocara canis and Toxocara cati--is it possible?

Authors:  C S Poulsen; S Skov; A Yoshida; P Skallerup; H Maruyama; S M Thamsborg; P Nejsum
Journal:  Parasite Immunol       Date:  2015-04       Impact factor: 2.280

5.  Experimental infection with Toxocara cati in BALB/c mice, migratory behaviour and pathological changes.

Authors:  N Cardillo; A Rosa; M Ribicich; C López; I Sommerfelt
Journal:  Zoonoses Public Health       Date:  2008-11-04       Impact factor: 2.702

6.  The investigation of Toxocara canis eggs in coats of different dog breeds as a potential transmission route in human toxocariasis.

Authors:  M Aydenizöz-Ozkayhan; B B Yağci; S Erat
Journal:  Vet Parasitol       Date:  2007-12-08       Impact factor: 2.738

Review 7.  Veterinary and public health aspects of Toxocara spp.

Authors:  Paul A M Overgaauw; Frans van Knapen
Journal:  Vet Parasitol       Date:  2012-12-20       Impact factor: 2.738

8.  Contamination of dog hair with eggs of Toxocara canis.

Authors:  Gillian Roddie; Peter Stafford; Celia Holland; Alan Wolfe
Journal:  Vet Parasitol       Date:  2007-12-15       Impact factor: 2.738

9.  Seroprevalence of Antibodies to Toxocara Species in the United States and Associated Risk Factors, 2011-2014.

Authors:  Eugene W Liu; Holly M Chastain; Sun Hee Shin; Ryan E Wiegand; Deanna Kruszon-Moran; Sukwan Handali; Jeffrey L Jones
Journal:  Clin Infect Dis       Date:  2018-01-06       Impact factor: 9.079

10.  Survey of UK pet owners quantifying internal parasite infection risk and deworming recommendation implications.

Authors:  Christopher Pennelegion; Jason Drake; Scott Wiseman; Ian Wright
Journal:  Parasit Vectors       Date:  2020-04-26       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.